{"id":"db04d86f-12aa-44cc-afd3-f6ee5defdb38","slug":"jacob-robinson","name":"Jacob Robinson","bioBrief":null,"priorExits":null,"nationality":null,"verificationPosture":"reported","aliases":[],"sources":[{"url":"https://www.businesswire.com/news/home/20260427361988/en/Motif-Neurotech-Receives-FDA-Approval-to-Begin-First-Clinical-Trial-of-its-Therapeutic-BCI-for-Treatment-Resistant-Depression","title":"Motif Neurotech Receives FDA Approval to Begin First Clinical Trial","sourceName":"Business Wire"}],"reviewStatus":"unreviewed","createdAt":"2026-08-08T22:38:45.240Z","updatedAt":"2026-08-08T22:38:45.240Z","educations":[],"companyRoles":[{"id":"7952f53d-c02a-476a-9a47-181a80565984","personId":"db04d86f-12aa-44cc-afd3-f6ee5defdb38","companyId":"0cd83b28-d0e9-4f17-be61-c9d20d2b618f","role":"ceo","roleTitle":"CEO & Co-founder","startDate":null,"endDate":null,"currentRole":true,"roleBasis":"verified_secondary","createdAt":"2026-08-08T22:38:46.026Z","company":{"slug":"motif-neurotech","name":"Motif Neurotech"}}],"boardRoles":[],"investorRoles":[],"foundings":[]}